World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
82968
World Ranking
3665
National Ranking
142

Overview

Harry J.G.M. Crijns is affiliated with Maastricht University Medical Centre in the Netherlands. Their research primarily focuses on medicine, with a specialization in cardiology and cardiovascular medicine.

The scientist's work spans several subfields including cardiology and cardiovascular medicine, surgery, radiology, nuclear medicine and imaging, molecular biology, and pulmonary and respiratory medicine.

Main topics of research include:

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Syncope and Autonomic Disorders

Crijns has published extensively in key cardiovascular journals. Frequent publication venues include:

  • EP Europace (41 publications)
  • European Heart Journal (25 publications)
  • Netherlands Heart Journal (10 publications)
  • Circulation (9 publications)
  • IJC Heart & Vasculature (9 publications)

Frequent co-authors in their research network are:

  • Ulrich Schotten (63 collaborations)
  • Isabelle C. Van Gelder (51 collaborations)
  • Dominik Linz (50 collaborations)
  • Michiel Rienstra (44 collaborations)
  • Paulus Kirchhof (36 collaborations)

Recent significant papers include:

  • 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), 2020, published in European Heart Journal
  • Early Rhythm-Control Therapy in Patients with Atrial Fibrillation, 2020, New England Journal of Medicine
  • 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), 2024, European Heart Journal
  • Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation, 2023, New England Journal of Medicine
  • How to use digital devices to detect and manage arrhythmias: an EHRA practical guide, 2022, EP Europace

Best Publications

  • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

    Gregory Y. H. Lip;Robby Nieuwlaat;Ron Pisters;Deirdre A. Lane

  • 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

    Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada

  • A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

    Ron Pisters;Deirdre A. Lane;Robby Nieuwlaat;Cees B. de Vos

  • 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

    Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada

  • HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation

    Hugh Calkins;Josep Brugada;Douglas L. Packer;Ricardo Cappato

  • Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

    Yanti Octavia;Carlo G. Tocchetti;Kathleen L. Gabrielson;Stefan Janssens

  • Effect of dronedarone on cardiovascular events in atrial fibrillation.

    Stefan H. Hohnloser;Martin van Eickels;Christophe Gaudin;Richard L. Page

  • 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    L. Samuel Wann;Anne B. Curtis;Kenneth A. Ellenbogen;N.A. Mark Estes

  • Atrial fibrillation management: a prospective survey in ESC Member Countries The Euro Heart Survey on Atrial Fibrillation

    Robby Nieuwlaat;Alessandro Capucci;A John Camm;S Bertil Olsson

  • Increased Mortality after Dronedarone Therapy for Severe Heart Failure

    Lars Køber;Christian Torp-Pedersen;John J.V. McMurray;Ole Gøtzsche

  • 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Valentin Fuster;Lars E. Rydén;Davis S. Cannom;Harry J. Crijns

  • Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

    Umesh C. Sharma;Saraswati Pokharel;Thomas J. van Brakel;Jop H. van Berlo

  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

  • 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

    Valentin Fuster;Lars E. Rydén;Davis S. Cannom;Harry J. Crijns

  • Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

    Bramah N. Singh;Stuart J. Connolly;Denis Roy;Peter R. Kowey

  • Progression From Paroxysmal to Persistent Atrial Fibrillation: Clinical Correlates and Prognosis

    Cees B. de Vos;Ron Pisters;Robby Nieuwlaat;Martin H. Prins

  • Multi-Ethnic Genome-wide Association Study for Atrial Fibrillation

    Carolina Roselli;Mark D. Chaffin;Lu Chen Weng;Lu Chen Weng;Stefanie Aeschbacher

  • Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure

    Roland R. van Kimmenade;James L. Januzzi;Patrick T. Ellinor;Umesh C. Sharma

  • Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

    Vincent E. Hagens;Adelita V. Ranchor;Eric Van Sonderen;Hans A. Bosker

  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: A report of the American College of Cardiology/American Heart Aassociation task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients With atrial fibrillation)Guidelines for the Management of Patients With Atrial Fibrillation)

    Jeffrey L. Anderson;Cynthia D. Adams;Elliott M. Antman;Charles R. Bridges

Frequent Co-Authors

Isabelle C. Van Gelder
Isabelle C. Van Gelder University Medical Center Groningen
Gregory Y.H. Lip
Gregory Y.H. Lip University of Liverpool
Paulus Kirchhof
Paulus Kirchhof University of Birmingham
A. John Camm
A. John Camm St George's, University of London
Frits W. Prinzen
Frits W. Prinzen Maastricht University
Giuseppe Boriani
Giuseppe Boriani University of Modena and Reggio Emilia
Martin H. Prins
Martin H. Prins Maastricht University
Deirdre A. Lane
Deirdre A. Lane University of Liverpool
Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Jan G.P. Tijssen
Jan G.P. Tijssen University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a diverse field with multiple career pathways and degree options to consider. For students seeking to enter allied health professions, exploring medical billing and coding financial aid opportunities can make education more accessible—and open doors to essential administrative roles in healthcare settings.

Nursing remains a highly sought-after profession for those passionate about patient care. Some absn programs that don't require teas exams offer accelerated transitions into nursing, helping students save time and reduce exam-related stress.

For those interested in leadership, management, or healthcare policy, there are accelerated healthcare programs available entirely online. These programs allow graduates to move quickly into high-impact positions across hospitals, clinics, and healthcare organizations.

Nurses aiming for advanced practice can also benefit from flexible educational options, such as asn to np programs. These bridge programs streamline the journey from nursing diploma or associate degrees to master’s-level qualifications, opening up broader clinical roles like Nurse Practitioner.

Best Scientists Citing Harry J.G.M. Crijns

Trending Scientists

Recently Published Articles